Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psoriasis
|
705 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.100 | 0.900 | 10 | 2007 | 2018 | |||||
Rheumatoid Arthritis
|
2387 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.060 | 0.833 | 6 | 2015 | 2020 | |||||
Arthritis, Psoriatic
|
89 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.040 | 1.000 | 4 | 2008 | 2019 | |||||
Liver carcinoma
|
942 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.040 | 0.750 | 4 | 2011 | 2017 | |||||
Malignant Neoplasms
|
1641 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.040 | 1.000 | 4 | 2009 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.040 | 1.000 | 4 | 2009 | 2017 | |||||
Hodgkin Disease
|
148 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.030 | 1.000 | 3 | 2012 | 2019 | |||||
Ankylosing spondylitis
|
609 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
cervical cancer
|
268 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2009 | 2012 | |||||
Cervix carcinoma
|
283 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2009 | 2012 | |||||
Esophageal carcinoma
|
272 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Esophageal Neoplasms
|
270 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Graves Disease
|
352 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||
Hepatitis C
|
347 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||
Huntington Disease
|
115 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Malignant neoplasm of esophagus
|
214 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||
Malignant tumor of cervix
|
245 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 1.000 | 2 | 2009 | 2012 | |||||
Multiple Sclerosis
|
1022 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.020 | 0.500 | 2 | 2016 | 2018 | |||||
Actinic cheilitis
|
8 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Acute Chest Syndrome
|
135 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Adenocarcinoma
|
168 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Adult Hodgkin Lymphoma
|
27 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Allergic rhinitis (disorder)
|
176 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Anthracosilicosis
|
4 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Asthma
|
1536 | 0.566 | 0.840 | 5 | 159315942 | 3 prime UTR variant | T/G | snv | 0.26 | 0.010 | 1.000 | 1 | 2011 | 2011 |